Facebook Twitter Instagram Linkedin Youtube
Facebook Twitter

Pandemic Latest News

Click Here

infectious diseases

Invasive mosquito species linked to unusual malaria outbreak

Leave a Comment / Featured, infectious diseases, Malaria, News, Newsletter /

Scientists have linked an invasive mosquito to an unusual outbreak of malaria in Ethiopia. Anopheles stephensi, native to southern Asia, was first identified in Africa a decade ago in the Republic of Djibouti, which borders Ethiopia. It has since spread to at least four other countries in sub-Saharan Africa. www.science.org/content/article/unusual-malaria-outbreak-tied-invasive-mosquito? Now, amid lingering questions about whether […]

Invasive mosquito species linked to unusual malaria outbreak Read More »

Pfizer announces promising results for RSV vaccine

Leave a Comment / Children, Featured, infectious diseases, News, Newsletter /

Barney Graham, a former scientist at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), was thrilled when Pfizer announced encouraging results from an experimental vaccine that could protect against a major childhood killer. In a press release, the company said immunizing pregnant women with its vaccine against respiratory syncytial virus (RSV) protected their babies from severe

Pfizer announces promising results for RSV vaccine Read More »

Vaccine trial against malaria shows promising results

Leave a Comment / Featured, infectious diseases, Malaria, News, Newsletter /

A new vaccine against malaria has shown promising preliminary results in a large trial in four African countries, boosting hopes that an additional tool may soon be available to help control the deadly disease. www.science.org/content/article/new-data-buoys-hopes-promising-malaria-vaccine-questions-remain The vaccine, named R21/Matrix-M and developed by researchers at the University of Oxford, produced similarly impressive results in a small trial last

Vaccine trial against malaria shows promising results Read More »

Pfizer set to test new COVID-19 pill on long-covid patients

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

Plans for the first test of whether Pfizer’s COVID-19 pill known as Paxlovid can alleviate Long Covid were unveiled last week, as organizers said they expect to begin recruiting 1700 volunteers in January 2023. Patient groups and researchers have long sought such a trial to study whether suppressing the SARS-CoV-2 coronavirus can reduce Long COVID’s debilitating

Pfizer set to test new COVID-19 pill on long-covid patients Read More »

More than 300 Omicron variants in circulation globally

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

BQ.1 and BQ.1.1 are among the more than 300 sub-lineages of the Omicron variant circulating globally, 95 percent of which are direct descendants of BA.5, according to the WHO. In early July, BA.5 became the dominant subvariant of the coronavirus circulating in the United States, but in October it started giving way to BQ.1 and

More than 300 Omicron variants in circulation globally Read More »

WHO reluctant to label new Omicron strains as variants of concern

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

Despite the fact that they’re driving a spurt in COVID cases, the World Health Organization (WHO) says XBB and BQ.1 are not different enough from each other, or from other Omicron lineages, to warrant labelling them new variants of concern. Variants of concern are those that show increased transmissibility, virulence or change in clinical disease,

WHO reluctant to label new Omicron strains as variants of concern Read More »

Tuberculosis rates rise post-COVID

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

COVID, the new pandemic has made an old one worse. After many years of slow but steady decline, the number of deaths from tuberculosis (TB) is rising again. www.economist.com/international/2022/10/27/how-one-pandemic-made-another-one-worse? According to figures published on October 27 by the WHO’s  Global TB Programme, the death toll from tuberculosis was 1.6m in 2021, a rise of 14

Tuberculosis rates rise post-COVID Read More »

Shanghai rolls out inhalable COVID-19 vaccine

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine last Wednesday in what appears to be a world first. www.pbs.org/newshour/world/china-begins-administering-inhalable-covid-19-vaccine-boosters? The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated people, according to an announcement on an official city social

Shanghai rolls out inhalable COVID-19 vaccine Read More »

Wuhan locked down once more due to COVID-19

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 /

Wuhan, locked down one of its central districts after Covid cases were found, as China persists with a zero-tolerance approach to the virus almost three years since the pathogen first emerged in the city. The roughly 900,000 residents of Hanyang district were told to stay in their homes from Wednesday, a spokeswoman from the area’s

Wuhan locked down once more due to COVID-19 Read More »

About Us

Health Issues Africa is a web portal that tracks key health stories and issues in Africa. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Facebook Twitter

Newsletter

Subscribe our newsletter to stay updated

Copyright © 2023 | Health Issues Africa | All rights reserved.